Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Biomind Labs Inc.

News headline image
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
From Biomind Labs Inc.
Via Business Wire
Tickers BMNDF
News headline image
Biomind Labs Doses First Subject in Phase I/IIa Clinical Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression
From Biomind Labs Inc.
Via Business Wire
News headline image
Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form
From Biomind Labs Inc.
Via Business Wire
News headline image
Biomind Labs to Advance a Phase II Clinical Trial on DMT for Treatment-Resistant Depression
From Biomind Labs Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.